Patient perspectives of lithium and quetiapine augmentation treatment in treatment‐resistant depression: a qualitative assessment
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background: Treatment-resistant depression (TRD) has a profound cost to patients and healthcare services worldwide. Pharmacological augmentation is one therapeutic option for TRD, with lithium and quetiapine currently recommended as first-line agents. Patient opinions about pharmacological augmentation may affect treatment outcomes, yet these have not been systematically explored. Aims: This study aimed to qualitatively assess patient experiences of lithium and quetiapine augmentation. Methods: Semi-structured interviews were conducted with 32 patients from the ongoing lithium versus quetiapine open-label trial comparing these augmentation agents in patients with TRD. Interviews were audio recorded, transcribed and a thematic analysis was used to assess patient opinions of each agent. Results: Four main themes were generated from the thematic analysis: ‘Initial concerns’, ‘Experience of side effects’, ‘Perception of treatment efficacy’ and ‘Positive perception of treatment monitoring’. Patient accounts indicated a predominantly positive experience of lithium and quetiapine augmentation. Greater apprehension about side effects was reported for lithium prior to treatment initiation, but greater experience of negative side effects was reported for quetiapine. Clinical monitoring was perceived positively. Conclusion: Patient accounts suggested treatment augmentation with lithium or quetiapine was acceptable and helpful for most patients. However, anticipation and experiences of adverse side effects may prevent some patients from benefitting from these treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Combination antidepressants, switching antidepressant treatment, dose optimization and the use of a host of augmentation strategies (e.g., lithium, thyroid hormone) have mixed data supporting their usefulness 288 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [288]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414 · cited 2×
“Data was analysed using thematic analysis, a widely used approach to identify patterns and higher levels of meaning within qualitative data (Braun and Clarke, 2006).”
MethodResearch Methods for Clinical and Health Psychology
Marks, D., & Yardley, L. (2004) · SAGE Publications Ltd eBooks · doi:10.4135/9781849209793 · Cited by 901 · cited 1×
“Thematic analysis was chosen as it is considered appropriate for analysing the views and experiences of patients (Marks and Yardley, 2004).”
MethodOliver, D. G., Serovich, J. M., & Mason, T. L. (2005) · Social Forces · doi:10.1353/sof.2006.0023 · Cited by 897
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · cited 1×
“Therapeutic options for patients with TRD include increasing the dose of ongoing antidepressant treatment, switching to an alternative antidepressant, combining antidepressants or augmentation with another agent (Cleare et al., 2015).”
BackgroundSelf-citationQualitative methods in research on healthcare quality
Pope, C. (2002) · Quality and Safety in Health Care · doi:10.1136/qhc.11.2.148 · Cited by 602 · cited 2×
“Qualitative research can describe and interpret complex phenomena involving the views, beliefs and experiences of patients (Pope et al., 2002) and identify subjective factors influencing patient outcomes (Rusinová et al., 2009).”
BackgroundNierenberg, A. A., Fava, M., Trivedi, M. H., Wisniewski, S. R., Thase, M. E., McGrath, P. J., Alpert, J. E., Warden, D., Luther, J. F., Niederehe, G., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1519 · Cited by 559 · cited 2×
“, 2018), with rates that may exceed 40% of patients (Nierenberg et al., 2006).”
BackgroundQualitative research and evidence based medicine
Green, J., & Britten, N. (1998) · BMJ · doi:10.1136/bmj.316.7139.1230 · Cited by 491
Overgeneral autobiographical memory as a predictor of the course of depression: A meta-analysis
Sumner, J. A., Griffith, J. W., & Mineka, S. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.03.013 · Cited by 413 · cited 1×
“Retrieval of autobiographical information is impaired in patients with depression, with less detailed and over-generalised recall predicting poor prognosis (Hitchcock et al., 2019; Sumner et al., 2010).”
BackgroundAvery, A., Anderson, C., Bond, C., Fortnum, H., Gifford, A., Hannaford, P., Hazell, L., Krska, J., Lee, A., McLernon, D., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15200 · Cited by 331 · cited 1×
“Indeed, previous research has demonstrated the additional value of patient reporting of adverse effects for pharmacovigilance alongside healthcare providers’ reports (Avery et al., 2011).”
BackgroundSleep Disturbances in Depression
Murphy, M. J., & Peterson, M. J. (2015) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2014.11.009 · Cited by 318 · cited 1×
“Our findings therefore underline the importance of considering individual patient characteristics and symptom experiences when making treatment decisions (Murphy and Peterson, 2015).”
BackgroundA Multidimensional Tool to Quantify Treatment Resistance in Depression: The Maudsley Staging Method
Fekadu, A., Wooderson, S., Donaldson, C., Markopoulou, K., Masterson, B., Poon, L., & Cleare, A. J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04309 · Cited by 281 · cited 1×
“Patients with TRD have significantly higher rates of mortality, poorer prognosis and twice the individual healthcare costs of patients with nonrefractory depression (Fekadu et al., 2009; Reutfors et al., 2018; Sussman et al., 2019).”
BackgroundSelf-citationLaferton, J. A. C., Kube, T., Salzmann, S., Auer, C. J., & Shedden-Mora, M. C. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.00233 · Cited by 267 · cited 1×
“Despite evidence that patient opinions have a direct impact on treatment outcomes (Laferton et al., 2017; Mergl et al., 2011), qualitative accounts have rarely informed current treatment guidelines (McPherson and Beresford, 2019).”
BackgroundBauer, M., Pretorius, H. W., Constant, E. L., Earley, W. R., Szamosi, J., & Brecher, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04629 · Cited by 210 · cited 1×
“Patients described difficulties with appetite increase, weight gain, restlessness and constipation, consistent with previously reported side effects associated with quetiapine (Bauer et al., 2009; El-Khalili et al., 2010).”
ResultEl-Khalili, N., Joyce, M., Atkinson, S., Buynak, R. J., Datto, C., Lindgren, P., & Eriksson, H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000015 · Cited by 185 · cited 1×
“Patients described difficulties with appetite increase, weight gain, restlessness and constipation, consistent with previously reported side effects associated with quetiapine (Bauer et al., 2009; El-Khalili et al., 2010).”
ResultTreatment adequacy for anxiety and depressive disorders in six European countries
Fernández, A., Haro, J. M., Martinez-Alonso, M., Demyttenaere, K., Brugha, T. S., Autonell, J., De Girolamo, G., Bernert, S., Lépine, J. P., & Alonso, J. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023507 · Cited by 171 · cited 2×
“Many patients with depression are undertreated (Fernández et al., 2007), and adequate treatment of TRD can improve prognosis (Wooderson et al.”
BackgroundPharmacological Treatments for Patients with Treatment-Resistant Depression
Ruberto, V. L., Jha, M. K., & Murrough, J. W. (2020) · Pharmaceuticals · doi:10.3390/ph13060116 · Cited by 147
Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis
Strawbridge, R., Carter, B., Marwood, L., Bandelow, B., Tsapekos, D., Nikolova, V. L., Taylor, R., Mantingh, T., de Angel, V., Patrick, F., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.233 · Cited by 140 · cited 3×
“There is evidence that pharmacological augmentation is effective in TRD (Strawbridge et al., 2019), with lithium and quetiapine among the agents with the strongest support.”
BackgroundSelf-citationMergl, R., Henkel, V., Allgaier, A.-K., Kramer, D., Hautzinger, M., Kohnen, R., Coyne, J., & Hegerl, U. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000318772 · Cited by 126 · cited 1×
“Despite evidence that patient opinions have a direct impact on treatment outcomes (Laferton et al., 2017; Mergl et al., 2011), qualitative accounts have rarely informed current treatment guidelines (McPherson and Beresford, 2019).”
BackgroundStandardisation framework for the Maudsley staging method for treatment resistance in depression
Fekadu, A., Donocik, J. G., & Cleare, A. J. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1679-x · Cited by 106 · cited 2×
“Treatment-resistant depression (TRD) is defined as suboptimal responses to two or more antidepressant trials of adequate dosage and duration in the current depressive episode (Fekadu et al., 2018), with rates that may exceed 40% of patients (Nierenberg et al.”
BackgroundSelf-citationLithium Augmentation in Antidepressant-Resistant Patients a Quantitative Analysis
Austin, M.-P. V., Souza, F. G. M., & Goodwin, G. M. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.159.4.510 · Cited by 97 · cited 1×
“Consistent with quantitative evidence, participants experienced difficulties with dry mouth, tremor and nausea (Austin et al., 1991; Hawley et al., 1994).”
BackgroundMortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors, J., Andersson, T. M.-L., Brenner, P., Brandt, L., DiBernardo, A., Li, G., Hägg, D., Wingård, L., & Bodén, R. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.030 · Cited by 94 · cited 1×
“Patients with TRD have significantly higher rates of mortality, poorer prognosis and twice the individual healthcare costs of patients with nonrefractory depression (Fekadu et al., 2009; Reutfors et al., 2018; Sussman et al., 2019).”
BackgroundLithium treatment for unipolar major depressive disorder: Systematic review
Undurraga, J. P., Sim, K., Tondo, L., Gorodischer, A., de Azúa, E. R., Tay, K. H., Tan, D. S. P., & Baldessarini, R. J. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118822161 · Cited by 94 · cited 1×
“Consistent with quantitative findings from previous studies, the participant accounts within this study highlighted several beneficial effects of both lithium and quetiapine, including reduction in symptoms and improvements in mood (Bauer et al., 2013; Undurraga et al., 2019).”
ResultQuetiapine augmentation of treatment-resistant depression: a comparison with lithium
Dorée, J.-P., Rosiers, J. D., Lew, V., Gendron, A., Elie, R., Stip, E., & Valérie Tourjman, S. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x162809 · Cited by 84 · cited 1×
“Contrasting with prior studies comparing these drugs, we found that adverse effects were perceived as more challenging with quetiapine than with lithium (Dorée et al., 2007).”
ResultPharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76 · cited 2×
“guidelines (Taylor et al., 2020), but the existing evidence does not favour one over the other, leading to clinical equipoise (Bauer et al.”
BackgroundSelf-citationBauer, M., Dell’Osso, L., Kasper, S. F., Pitchot, W., Vansvik, E. D., Köhler, J., Jørgensen, L., & Montgomery, S. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.079 · Cited by 73 · cited 4×
“Email: jess.kerr-gaffney@kcl.ac.uk guidelines (Taylor et al., 2020), but the existing evidence does not favour one over the other, leading to clinical equipoise (Bauer et al., 2013).”
BackgroundResultInfluentialZhu, M., Hong, R. H., Yang, T., Yang, X., Wang, X., Liu, J., Murphy, J. K., Michalak, E. E., Wang, Z., Yatham, L. N., et al. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.21r14034 · Cited by 68
Economic Burden of Treatment-Resistant Depression on the U.S. Health Care System
Sussman, M., O’sullivan, A. K., Shah, A., Olfson, M., & Menzin, J. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.25.7.823 · Cited by 65 · cited 1×
“Patients with TRD have significantly higher rates of mortality, poorer prognosis and twice the individual healthcare costs of patients with nonrefractory depression (Fekadu et al., 2009; Reutfors et al., 2018; Sussman et al., 2019).”
BackgroundQualitative research: Adding drive and dimension to clinical research
Rusínová, K., Pochard, F., Kentish‐Barnes, N., Chaize, M., & Azoulay, É. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819207e7 · Cited by 60 · cited 2×
“, 2002) and identify subjective factors influencing patient outcomes (Rusinová et al., 2009).”
BackgroundAnderson, I. M., Sarsfield, A., & Haddad, P. M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.016 · Cited by 44 · cited 1×
“Aligning with prior research, we found that experiences of adverse effects were nearly universal (Anderson et al., 2009; van Marwijk et al., 1990).”
MethodLithium augmentation in geriatric depression
van Marwijk, H., Bekker, F. M., Nolen, W. A., Jansen, P. A. F., Jf, V. N., & Hop, W. C. J. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90053-b · Cited by 35 · cited 1×
“Aligning with prior research, we found that experiences of adverse effects were nearly universal (Anderson et al., 2009; van Marwijk et al., 1990).”
MethodIs lithium monitoring NICE? Lithium monitoring in a UK secondary care setting
Nikolova, V. L., Pattanaseri, K., Hidalgo‐Mazzei, D., Taylor, D. M., & Young, A. H. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118760663 · Cited by 33 · cited 1×
“Finally, although the LQD study was a pragmatic study designed to reflect real-world practice, patients who are prescribed these medicines outside of a research context may not receive the same level of monitoring (Nikolova et al., 2018).”
BackgroundSelf-citationA retrospective examination of care pathways in individuals with treatment-resistant depression
Day, E., Shah, R., Taylor, R., Marwood, L., Nortey, K., Harvey, J., McAllister-Williams, H., Geddes, J. R., Alvaro Barrera, P., Young, A. H., et al. (2021) · BJPsych Open · doi:10.1192/bjo.2021.59 · Cited by 28 · cited 1×
“However, despite evidence of efficacy and guideline recommendations, augmentation is underused in clinical practice and there remains a proportion of patients who do not find augmentation adequately helpful (Day et al., 2021).”
BackgroundSelf-citationPatients’ Beliefs About Deep Brain Stimulation for Treatment-Resistant Depression
Lawrence, R. E., Kaufmann, C. R., DeSilva, R. B., & Appelbaum, P. S. (2018) · AJOB Neuroscience · doi:10.1080/21507740.2018.1553897 · Cited by 24 · cited 1×
“This finding is consistent with previous research indicating that patients with TRD are both thoughtful and cautious about trying novel therapies (Lawrence et al., 2018).”
ResultWooderson, S. C., Fekadu, A., Markopoulou, K., Rane, L. J., Poon, L., Juruena, M. F., Strawbridge, R., & Cleare, A. J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.013 · Cited by 22 · cited 2×
“, 2007), and adequate treatment of TRD can improve prognosis (Wooderson et al., 2014), highlighting the importance of appropriately treating the condition.”
BackgroundSelf-citationSemantics of patient choice: how the UK national guideline for depression silences patients
McPherson, S., & Beresford, P. (2019) · Disability & Society · doi:10.1080/09687599.2019.1589757 · Cited by 21 · cited 2×
“Despite evidence that patient opinions have a direct impact on treatment outcomes (Laferton et al., 2017; Mergl et al., 2011), qualitative accounts have rarely informed current treatment guidelines (McPherson and Beresford, 2019).”
BackgroundMarwood, L., Taylor, R., Goldsmith, K., Romeo, R., Holland, R., Pickles, A. R., Hutchinson, J. D., Dietch, D., Cipriani, A., Nair, R., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1393-0 · Cited by 20 · cited 2×
“The LQD study protocol has been published in full (Marwood et al., 2017).”
BackgroundSelf-citationHawley, C. J., Roberts, A., & Walker, M. H. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800412 · Cited by 16 · cited 1×
“Consistent with quantitative evidence, participants experienced difficulties with dry mouth, tremor and nausea (Austin et al., 1991; Hawley et al., 1994).”
BackgroundHitchcock, C., Rudokaite, J., Patel, S. D., Smith, A., Kuhn, I. L., Watkins, E. R., & Dalgleish, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031110 · Cited by 13 · cited 1×
“Retrieval of autobiographical information is impaired in patients with depression, with less detailed and over-generalised recall predicting poor prognosis (Hitchcock et al., 2019; Sumner et al., 2010).”
BackgroundAdd-on lithium for the treatment of unipolar depression: Too often forgotten?
Jollant, F. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140162 · Cited by 7
Research works printed but not linked: 1
- QSR International Ltd. (2012) NVivo 10 Doncaster, VIC, Australia: QSR International Ltd.
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationStrawbridge, R., & Young, A. H. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00325-y · Cited by 21
“Further reasons include complexities or inconveniences related to the need for regular blood monitoring, which appears to be present from patient (McKeown et al. 2022), clinician and service-level perspective (Nikolova et al. 2018).”
BackgroundSelf-citationLithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature
Acero-González, Á., Guzmán, Y., Proaños, N., Bustos, R., Aconcha, M., Guerrero, I., Martinez, L. A., Berk, M., & Dodd, S. (2025) · Pharmacotherapy · doi:10.1002/phar.70063 · Cited by 5
“Participants indicated a positive experience of lithium and quetiapine augmentation, although some patients held beliefs that suggested greater apprehension towards lithium than quetiapine [54].”
Quantitative evaluation of multiple treatment regimens for treatment-resistant depression
Feng, Y., Lv, Y., Yang, J., Xu, L., Chen, J., Huang, J., Ren, J., Zheng, Q., & Li, L. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf007 · Cited by 5
“…multiple neurotransmission pathways, is primarily used as an augmenting agent in combination with antidepressants for the treatment of TRD. 31,32 This study indicates that the combination of lithium with SSRIs/SNRIs is slightly less effective than the olanzapine or quetiapine combinations,…”
Strawbridge, R., Myrtle, S., Carmellini, P., Hampsey, E., Cousins, D. A., & Young, A. H. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251328282 · Cited by 3
“17,18 Its lack of pharmaceutical company promotion (unlike newer mood stabilizers) may also contribute to lithium ’ s underutilization.”
Self-citation
Metadata
- Authors
- McKeown, L., Taylor, R. W., Day, E., Shah, R., Marwood, L., Tee, H., Kerr-Gaffney, J., Oprea, E., Geddes, J. R., McAllister-Williams, R. H., Young, A. H., & Cleare, A. J.
- Affiliations
- King's College London (GB)
- Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
- Oxford Health NHS Foundation Trust (GB)
- Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2022-04-27
- Volume
- 36
- Issue
- 5
- Pages
- 557-565
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC9112618
- OpenAlex
- W4225005363
- Cited by
- 12
- References
- 39
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 2
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Health Technology Assessment Programme (14/222/02)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, drug augmentation, lithium, quetiapine, patient experience, adverse effects, treatment monitoring, treatment acceptability
- MeSH terms
- Quetiapine Fumarate, Antidepressive Agents, Depression, Drug Therapy, Combination, Humans, Lithium, Antipsychotic Agents, Treatment Outcome, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.